Research and Clinical Trials

Brief Description  
This study is a placebo-controlled randomized, double-blind study to compare overall survival of subjects with locally-advanced pancreatic cancer.
Who may be Eligible  

  • Histologic or cytologic documentation of adenocarcinoma of the pancreas
  • Unresectable disease due to local extension or invasion, for example:
    • Tumor extension precluding resection, eg, to mesenteric or retroperitoneal structures, vascular encasement, etc, or
    • Lymph node involvement beyond the surgical field
  • Recovery from toxicity of previous procedures that establish diagnosis of locally-advanced disease (patients with previous pancreatic resection are excluded)
  • ECOG PS 0 or 1
IRB Number  
Principal Investigator  
Salmon, Stuart

For More Information, Contact  Delois  , DeShazo
Phone:  (704) 355-1342  Fax:  (704) 355-1353  
Address:1100 South Tryon Street Suite 220 Charlotte, NC 28203